Skip to main content
Elsevier

Personalized Cancer Medicine through Multiomics

  • 1st Edition - November 15, 2026
  • Latest edition
  • Editors: Mohammad Azhar Aziz, Snober Shabnam Mir
  • Language: English

Personalized Cancer Medicine through Multiomics explores the groundbreaking integration of multiomics to transform cancer diagnosis and treatment. The book delves into how the co… Read more

Description

Personalized Cancer Medicine through Multiomics explores the groundbreaking integration of multiomics to transform cancer diagnosis and treatment. The book delves into how the convergence of genomics, transcriptomics, proteomics, and metabolomics offers a comprehensive understanding of cancer biology, surpassing traditional single-omics approaches. Sections detail advancements in high-throughput technologies and computational methods, including machine learning, that enable the analysis of complex cancer datasets. Additional content discusses how multiomics identifies unique molecular signatures, novel therapeutic targets, and biomarkers, facilitating precise and individualized treatment strategies, particularly for heterogeneous cancers.

For academics, this book serves as an essential resource, compiling fragmented research into a single, coherent volume. It provides foundational knowledge, the latest advancements, and practical applications of multiomics in personalized medicine. Researchers will benefit from interdisciplinary approaches, real-world examples, and cutting-edge methodologies, making it an invaluable reference for advancing their work in oncology.

Key features

  • Presents an in-depth exploration of genomics, transcriptomics, proteomics, and metabolomics, providing a holistic understanding of cancer biology that surpasses traditional single-omics approaches
  • Details the latest advancements in high-throughput technologies and machine learning, enabling the analysis of complex cancer datasets
  • Includes real-world case studies and practical insights, illustrating successful applications of multiomics in personalized medicine

Readership

Academic researchers and professionals in the fields of oncology, genomics, bioinformatics, and clinical medicine

Table of contents

1. Introduction about omics

2. Cancer Genomics

3. Cancer Transcriptomics

4. Cancer Proteomics

5. Cancer Metabolomics

6. Cancer lipidomics

7. Cancer and other omics

8. Cancer is a systems biology disease: Why multiomics is relevant for cancer?

9. Tools and techniques for integration of data from multiomics

10. Biomarker discovery through multiomics approach

11. Identification of therapeutic targets by employing multiomics

12. Multiomics for an individual patient: Relevance and possibilities

13. Personalized medicine: Fact or Fiction/ Hope or Hype?

14. Clinical translation of multiomics approach

15. Ethical aspects of personalized medicine

16. Economics of multiomics and personalized medicine

Product details

  • Edition: 1
  • Latest edition
  • Published: November 15, 2026
  • Language: English

About the editors

MA

Mohammad Azhar Aziz

Dr. Mohammad Azhar Aziz graduated from Jawaharlal Nehru university with PhD in Biotechnology. During PhD, he did pioneer work on anthrax vaccine development. He is a molecular biologist with domain expertise in Cancer biology. His interdisciplinary training enabled him to put together several disciplines and departments to address a scientific problem. He has successfully utilized nanoparticles to selectively target leukemia. He is an expert in Cancer Research with pioneer work on precision and personalized medicine in colorectal cancer with an integrative approach. He established 'Cancer Nanomedicine' Consortium at Aligarh Muslim University to bring together different departments for conducting cancer research and find translatable solutions for the patients.
Affiliations and expertise
Aligarh Muslim University, India

SM

Snober Shabnam Mir

Snober S. Mir is working as Professor and Head, Department of Biosciences, Integral University, Lucknow. Her area of specialization is Molecular and Cell Biology, Cancer Biology and Yeast Biology. She has been a recipient of the Young Scientist Award by IACR during her doctoral studies and a research fellowship of PGIMER. Dr. Mir worked as a Postdoctoral Fellow at the Medical College of Georgia, USA and as Senior Research Associate on a European Commission funded project at CSIR-CDRI, Lucknow. Her research work in cancer biology is funded by DBT, YSS-SERB, CRG-ANRF, ARG-ANRF and SERB-SURE grants. The research group also trains DAAD-RISE interns under the German Academic Exchange Service funded by DAAD-RISE Worldwide.

Affiliations and expertise
Integral University, Lucknow, India